acetylcysteine has been researched along with Benign Mastocytoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SJ; Jeong, MH; Jeong, SJ; Kim, KH; Lee, SW; Park, BS; Seo, SY; Song, KH; Yoo, KS; Yoo, YH | 1 |
| Jun, EJ; Jung, SM; Kim, JK; Kim, KH; Kim, ND; Lee, S; Lim, YJ; Park, BS; Seo, SY; Suh, H; Yoo, YH | 1 |
| Bağriaçik, EÜ; Karasu, C; Stefek, M; Uslu, K; Yurtçu, E | 1 |
3 other study(ies) available for acetylcysteine and Benign Mastocytoma
| Article | Year |
|---|---|
Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cysteine Endopeptidases; Drug Synergism; Genistein; Mast Cells; Mastocytoma; Mice; Multienzyme Complexes; NF-kappa B; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 2002 |
Synthetic chenodeoxycholic acid derivative HS-1200-induced apoptosis of p815 mastocytoma cells is augmented by co-treatment with lactacystin.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Chenodeoxycholic Acid; Cysteine Endopeptidases; DNA Fragmentation; Drug Synergism; Mastocytoma; Membrane Potentials; Mice; Mitochondria; Multienzyme Complexes; Poly(ADP-ribose) Polymerases; Proteasome Endopeptidase Complex | 2003 |
Stobadine inhibits doxorubicin-induced apoptosis through a caspase-9 dependent pathway in P815 mastocytoma cells.
Topics: Acetylcysteine; Animals; Antioxidants; Apoptosis; Carbolines; Caspase 9; Caspase Inhibitors; Doxorubicin; Mastocytoma; Mice; Necrosis | 2007 |